Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
Go back to Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.61 | 52 Week High | $0.45 | |||
| Open | $48.61 | 52 Week Low | $0.37 | |||
| Day High | $48.61 | P/E | N/A | |||
| Day Low | $48.61 | EPS | $-0.31 | |||
| Volume | 11,786 | |||||
